NCT07488052 Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG)
| NCT ID | NCT07488052 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Defense Medical Center, Taiwan |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2026-03-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective multicenter observational study will validate the accuracy of a previously developed artificial intelligence-enabled single-lead electrocardiogram (AI-ECG) model for identifying low ejection fraction and other structural heart disease phenotypes. Adult participants receiving a model-compatible single-lead electrocardiogram (ECG) (Apple Watch and QOCA ECG102D) and transthoracic echocardiography at five hospitals in Taiwan will be enrolled between March 1, 2026 and June 30, 2026. Model predictions will be compared with echocardiographic reference standards obtained within 30 days after the index ECG.
Eligibility Criteria
Inclusion Criteria: * Age 20 years or older * Single-lead ECG recorded using a study-compatible device * Ability to comply with study procedures and, when applicable, provide informed consent according to local institutional review board (IRB) requirements * No transthoracic echocardiography performed within 90 days before the index ECG Exclusion Criteria: * ECG signal quality insufficient for prespecified AI analysis * No transthoracic echocardiography available within 30 days after the index ECG * Echocardiography unavailable or technically inadequate for determining left ventricular ejection fraction (EF)
Contact & Investigator
CHIN LIN, PhD
PRINCIPAL INVESTIGATOR
National Defense Medical Center
Frequently Asked Questions
Who can join the NCT07488052 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07488052 currently recruiting?
Yes, NCT07488052 is actively recruiting participants. Contact the research team at xup6fup0629@gmail.com for enrollment information.
Where is the NCT07488052 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07488052 clinical trial?
NCT07488052 is sponsored by National Defense Medical Center, Taiwan. The principal investigator is CHIN LIN, PhD at National Defense Medical Center. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.